Migal Research Institute Archives

Israel’s MigVax Receives $4.3M Award For Development Of Oral Vaccine

The funding is part of a $200 million CEPI program to advance the development of vaccines that provide protection against COVID-19 variants.

News Briefs

November 07, 2021

A scientist at the Migal Research Institute's lab where researchers are working on developing a coronavirus vaccine. March 2020. Courtesy

Israeli Team Developing Coronavirus Vaccine Raises $12M For New Startup, To Begin Summer Trials

The new company, MigVax, is an affiliate of The Migal Galilee Research Institute and will pioneer the effort to develop the vaccine.

Science

April 22, 2020

A scientist at the Migal Research Institute's lab where researchers are working on developing a coronavirus vaccine. March 2020. Photo: Lior Jorno

Israeli Scientists Work To Test Adapted New Avian Virus Vaccine Against Human Coronavirus

Researchers at the Migal Institute in northern Israel say they developed an effective vaccine against IBV, a fowl virus, and are now working to adapt it to COVID-19.

Science

March 03, 2020